Becton Dickinson & Company
NYSE: BDX
$221.98
-$2.27 (-1.0%)
Closing Price on November 27, 2024
BDX Articles
Friday's top analyst upgrades and downgrades included Alteryx, Booking, CarGurus, Datadog, FedEx, First Solar, Uber Technologies, Vonage, Yeti and Zillow.
Published:
Investors look at Aytu BioScience as it looks at expanding in the COVID testing field.
Published:
With the focus on health care expected to remain center stage for 2020, these Raymond James top health care stock picks all make sense now.
Published:
Monday's top analyst upgrades and downgrades included Amazon.com, Canopy Growth, CarMax, Chipotle Mexican Grill, Geron, Hess, Inogen, Occidental Petroleum, Snap, Teva Pharmaceutical, Vail Resorts and...
Published:
Aytu BioScience has a distribution agreement for a COVID-19 rapid test and is developing a potential UV light-based treatment.
Published:
This specialty pharmaceutical company is making good progress on multiple fronts, including changes to its board of directors and with its test for and treatment of COVID-19.
Published:
Aytu BioScience has been one of the biggest winners in the fight against the novel coronavirus. The company is sending 2,700 COVID-19 rapid tests to Denver for use with first responders.
Published:
Co-Diagnostics has been the toast of Wall Street after it went from penny stock status to a revered coronavirus testing stock.
Published:
GenMark Diagnostics shares shot up early on Wednesday after the company provided an update on its quarterly numbers and where it stands with its coronavirus test.
Published:
Co-Diagnostics shares popped on Monday after the company announced a key update from the FDA on its COVID-19 test kit.
Published:
Becton, Dickinson is officially throwing its hat in the ring to fight COVID-19. Specifically, this firm is working on the front end by testing for the disease and antibodies that have been built up...
Published:
Thursday's top analyst upgrades, downgrades and initiations included Abbott Laboratories, Alexion Pharmaceuticals, Avis Budget, DexCom, Johnson & Johnson, Marvell Technology, Moderna, Snap, Splunk...
Published:
Friday's top analyst upgrades, downgrades and initiations included Cardinal Health, Domino's, FedEx, Ford, General Electric, Grubhub, HSBC, Marvell Technology, Twitter and Uber.
Published:
These four health care stocks look like solid picks for the fourth quarter and into 2020. They are also favorite picks from Raymond James analysts.
Published:
Last Updated:
These five Raymond James analyst favorite stock picks have substantial upside potential to the price targets and would make solid portfolio additions at current price levels.
Published:
Last Updated: